يعرض 1 - 20 نتائج من 253 نتيجة بحث عن '"Vandana G. Abramson"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal
    Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer

    المؤلفون: Vandana G. Abramson, Ingrid A. Mayer

    المصدر: Therapeutic Advances in Medical Oncology, Vol 4 (2012)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1758-8340; https://doaj.org/toc/1758-8359

    URL الوصول: https://doaj.org/article/41f38344531f44f89d7be8b0aed895e7

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Supplementary Figure 5 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183976

    الاتاحة: https://doi.org/10.1158/2159-8290.25183976.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183976

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    Supplementary Figure 7 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_7_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183970

    الاتاحة: https://doi.org/10.1158/2159-8290.25183970.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_7_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183970

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    Supplementary Figure 6 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183973

    الاتاحة: https://doi.org/10.1158/2159-8290.25183973.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183973

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Academic Journal
    Supplementary Figure 8 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_8_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183967

    الاتاحة: https://doi.org/10.1158/2159-8290.25183967.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_8_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183967

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Academic Journal
    Supplementary Figure 4 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183979

    الاتاحة: https://doi.org/10.1158/2159-8290.25183979.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183979

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Academic Journal
    Supplementary Figure 3 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183982

    الاتاحة: https://doi.org/10.1158/2159-8290.25183982.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183982

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Academic Journal
    Supplementary Figure 1 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183988

    الاتاحة: https://doi.org/10.1158/2159-8290.25183988.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183988

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Academic Journal
    Supplementary Figure 2 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183985

    الاتاحة: https://doi.org/10.1158/2159-8290.25183985.v1
    https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183985

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Academic Journal
    Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer

    المؤلفون: Chi Yan, Jinming Yang, Nabil Saleh, Sheau-Chiann Chen, Gregory D. Ayers, Vandana G. Abramson, Ingrid A. Mayer, Ann Richmond

    المصدر: International Journal of Molecular Sciences; Volume 22; Issue 10; Pages: 5207

    مصطلحات موضوعية: PI3K/mTOR, breast cancer, immune checkpoint inhibitor, cytotoxic T cells

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    Relation: Molecular Biology; https://dx.doi.org/10.3390/ijms22105207

    الاتاحة: https://doi.org/10.3390/ijms22105207

    View record in BASE

    أضف إلى المفضلة
  11. 11
    Supplementary Table 1 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/dataset/Supplementary_Table_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183964

    الاتاحة: https://doi.org/10.1158/2159-8290.25183964.v1
    https://figshare.com/articles/dataset/Supplementary_Table_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183964

    View record in BASE

    أضف إلى المفضلة
  12. 12
    Supplementary Table 2 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/dataset/Supplementary_Table_2_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183961

    الاتاحة: https://doi.org/10.1158/2159-8290.25183961.v1
    https://figshare.com/articles/dataset/Supplementary_Table_2_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183961

    View record in BASE

    أضف إلى المفضلة
  13. 13
    Supplementary Data 1 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    المؤلفون: Brandie C. Taylor, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gomez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa-Maria, Payal D. Shah, Elizabeth C. Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    مصطلحات موضوعية: Cancer, Immuno-oncology, Immunotherapy, Combination immunotherapy

    Relation: https://figshare.com/articles/dataset/Supplementary_Data_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183991

    الاتاحة: https://doi.org/10.1158/2159-8290.25183991.v1
    https://figshare.com/articles/dataset/Supplementary_Data_1_from_NKG2A_Is_a_Therapeutic_Vulnerability_in_Immunotherapy_Resistant_MHC-I_Heterogeneous_Triple-Negative_Breast_Cancer/25183991

    View record in BASE

    أضف إلى المفضلة
  14. 14
    Academic Journal
    Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer

    المؤلفون: Jennifer G. Whisenant, Jason M. Williams, Hakmook Kang, Lori R. Arlinghaus, Richard G. Abramson, Vandana G. Abramson, Kareem Fakhoury, A. Bapsi Chakravarthy, Thomas E. Yankeelov

    المصدر: Tomography; Volume 6; Issue 2; Pages: 170-176

    مصطلحات موضوعية: FDG-PET, pathological complete response, quantitative PET, 18F-fluorodeoxyglucose

    وصف الملف: application/pdf

    Relation: https://dx.doi.org/10.18383/j.tom.2020.00002

    الاتاحة: https://doi.org/10.18383/j.tom.2020.00002

    View record in BASE

    أضف إلى المفضلة
  15. 15
    Supplementary Fig. S1 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    المؤلفون: Ian E. Krop, Eric P. Winer, Franziska Michor, Kornelia Polyak, Tari A. King, Leila Russo, Patrizia Dell'Orto, Aditya Bardia, Michelle K. DeMeo, Eileen Wrabel, Adrienne G. Waks, Laura M. Spring, Carlos L. Arteaga, Vandana G. Abramson, Ingrid A. Mayer, Denise A. Yardley, Lorenzo Trippa, Shayna Stein, Giuseppe Viale, Otto Metzger Filho

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8aedc7b8facd30ae5fdfd8dec38a2a
    https://doi.org/10.1158/2159-8290.22538948

    View record in OpenAIRE

    أضف إلى المفضلة
  16. 16
    Supplementary Table S2 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    المؤلفون: Ian E. Krop, Eric P. Winer, Franziska Michor, Kornelia Polyak, Tari A. King, Leila Russo, Patrizia Dell'Orto, Aditya Bardia, Michelle K. DeMeo, Eileen Wrabel, Adrienne G. Waks, Laura M. Spring, Carlos L. Arteaga, Vandana G. Abramson, Ingrid A. Mayer, Denise A. Yardley, Lorenzo Trippa, Shayna Stein, Giuseppe Viale, Otto Metzger Filho

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70029c4a13c0e215d7eb9c8e6691c2bd
    https://doi.org/10.1158/2159-8290.22538927

    View record in OpenAIRE

    أضف إلى المفضلة
  17. 17
    Data from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    المؤلفون: Ian E. Krop, Eric P. Winer, Franziska Michor, Kornelia Polyak, Tari A. King, Leila Russo, Patrizia Dell'Orto, Aditya Bardia, Michelle K. DeMeo, Eileen Wrabel, Adrienne G. Waks, Laura M. Spring, Carlos L. Arteaga, Vandana G. Abramson, Ingrid A. Mayer, Denise A. Yardley, Lorenzo Trippa, Shayna Stein, Giuseppe Viale, Otto Metzger Filho

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a398926894d3f2961bea956ef7d118f7
    https://doi.org/10.1158/2159-8290.c.6548945

    View record in OpenAIRE

    أضف إلى المفضلة
  18. 18
    Supplemental Figure 4 from A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67

    المؤلفون: Jennifer A. Pietenpol, Carlos L. Arteaga, Sheau-Chiann Chen, Quanhu Sheng, Yu Shyr, Brian D. Lehmann, Ana M. Grau, Ingrid M. Meszoely, Jenny C. Chang, Andres Forero-Torres, Patrick M. Dillon, Jennifer M. Rosenbluth, Violeta Sanchez, Kimberly C. Johnson, Timothy M. Shaver, J. Scott Beeler, Monica V. Estrada, M. Gabriela Kuba, Melinda E. Sanders, Aditya Bardia, Vandana G. Abramson, Erica L. Mayer, Ingrid A. Mayer, Bojana Jovanović

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5de16bb250e91312c59358ce39c53e4f
    https://doi.org/10.1158/1078-0432.22468109

    View record in OpenAIRE

    أضف إلى المفضلة
  19. 19
    Supplementary fig 1 from Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

    المؤلفون: Justin M. Balko, Roberto Salgado, Ingrid A. Mayer, Melinda E. Sanders, Todd W. Miller, Kevin Shee, Jonathan D. Marotti, Ana C. Garrido-Castro, Ian E. Krop, Sara M. Tolaney, Joshua Donaldson, Simon Mallal, Valerie M. Jansen, Vandana G. Abramson, Brent N. Rexer, Sean Mackay, Jing Zhou, Sherene Loi, Susan R. Opalenik, Violeta Sanchez, Wyatt J. McDonnell, Mark A. Pilkinton, Riley E. Bergman, Paula I. Gonzalez-Ericsson, Mellissa J. Nixon, Margaret L. Axelrod

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa41b9b0c1df96ccffbe452bec57b07
    https://doi.org/10.1158/1078-0432.22478006.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  20. 20
    Supplementary Dataset 2 from Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

    المؤلفون: Justin M. Balko, Roberto Salgado, Ingrid A. Mayer, Melinda E. Sanders, Todd W. Miller, Kevin Shee, Jonathan D. Marotti, Ana C. Garrido-Castro, Ian E. Krop, Sara M. Tolaney, Joshua Donaldson, Simon Mallal, Valerie M. Jansen, Vandana G. Abramson, Brent N. Rexer, Sean Mackay, Jing Zhou, Sherene Loi, Susan R. Opalenik, Violeta Sanchez, Wyatt J. McDonnell, Mark A. Pilkinton, Riley E. Bergman, Paula I. Gonzalez-Ericsson, Mellissa J. Nixon, Margaret L. Axelrod

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef860d9ab2a4e9480c9c1787633aa07
    https://doi.org/10.1158/1078-0432.22478012

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء